In vitro studies to assess biocompatibility of peritoneal dialysis solutions: Strengths and limitations

Peritoneal Dialysis International

Volumn 16, Issue SUPPL. 1, 1996, Pages

  Breborowicz, Andrzej ^a,c   Oreopoulos, Dimitrios G ^b  

^a Medical School   (Poland)

^b UNIVERSITY OF TORONTO   (Canada)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Biocompatibility; In vitro tests

Indexed keywords

DIALYSIS FLUID;

BIOCOMPATIBILITY; CELL CULTURE; CONFERENCE PAPER; FIBROBLAST; HUMAN; HUMAN CELL; LEUKOCYTE; MESOTHELIUM CELL; PRIORITY JOURNAL;

EID: 0030006937     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089601601s21     Document Type: Conference Paper

References (28)

1. Van Bronswijk H, Verbrugh HA, Bos HJ,et al. Cytotoxic effects of commercial continuous ambulatory peritoneal dialysis (CAPD) fluids and of bacterial exoproducts on human mesothelial cells in vitro. Perit Dial Int 1989; 9:197-202.
2. Kristensen SR, Pedersen FB. Cytotoxicity testing of two CAPD dialysis fluids in a model system of quiescent fibroblasts. Nephrol Dial Transplant 1993; 8:163-7.
3. Jörres A, Gahl GM. Effect of peritoneal dialysis fluids on leukocyte function. Perit Dial Int 1994; 14 (Suppl 3):S29-S32.
4. Ing BL, Gupta DK, Nawab ZM, et al. Suppression of neutrophil Superoxide production by conventional peritoneal dialysis solutions. Int J Artif Organs 1988; 11:351-4.
5. Liberek T, Topley N, Jörres A,et al. Peritoneal dialysis fluid inhibition of phagocyte function: effects of osmolality and glucose concentration.J Am Soc Nephrol 1993; 3:1508-15.
6. Liberek T, Topley N, Jörres A,et al. Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH. Nephron 1993; 65:260-5.
7. Wieslander AP, Nordin MK, Martinson E, et al. Heat sterilized PD fluids impair growth and inflammatory responses of cultured cell lines and human leukocytes. Clin Nephrol 1993; 39:343-8.
8. Duwe AK, Vas SI, Weatherhead JW. Effects of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis and bactericidal activity in vitro. Infect Immun 1981; 33:130-5.
9. Dobbie JW, Lloyd JK, Gall CA. Categorization of ultrastructural changes in peritoneal mesothelium, stroma and blood vessels in uremia and CAPD patients. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin Inc., 1990; 6:3-12.
10. Heimburger O, Waniewski J, Werynski A, et al. Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int 1990; 38:495-506.
11. Dobbie JW, Pavlina T, Lloyd JK,et al. In vitro systems for testing effect of dialysate composition on mesothelium. Perit Dial Int 1990; 10 (Suppl 1):S51.
12. Breborowicz A, Karon J, Korybalska K, et al. Properties of mesothelial cells exposed to glucose or amino acid based dialysate effluents. Perit Dial Int 1995; 15 (Suppl 1):S76.
13. Gotloib L, Wajsbrot V, Shostack A, et al. Experimental approach to peritoneal morphology.Perit Dial Int 1994; 14 (Suppl 3):S6-S11.
14. Chamberlin ME, Strange K. Anisoosmotic cell volume regulation: a comparative view. Am J Physiol 1989; 257:C159-C173.
15. Gallimore B, Gagnon RF, Stevenson MM. Cytotoxicity of commercial peritoneal dialysis solutions towards peritoneal cells of chronically uremic mice. Nephron 1986; 43:283-9.
16. Jörres A, Jörres D, Topley N,et al. Leukotriene release from peripheral and peritoneal leukocytes following exposure to peritoneal dialysis solutions.Nephrol Dial Transplant 1991; 6:495-501.
17. Topley N, Mackenzie R, Petersen MM, et al. In vitro testing of a potentially biocompatible continuous ambulatory peritoneal dialysis fluid.Nephrol Dial Transplant 1991; 6:574-81.
18. Breborowicz A, Martis L, Oreopoulos DG. Changes in biocompatibility of dialysis fluid during its dwell in the peritoneal cavity. Perit Dial Int 1995; 15:152-70.
19. Haussinger D, Lang F, Gerok W. Regulation of cell function by the cellular hydration state. Am J Physiol 1994; 267:E343-E355.
20. Witowski J, Topley N, Jörres A, et al. Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis. Kidney Int 1994; 46:282-93.
21. Breborowicz A, Rodela H, Martis L, Oreopoulos DG. Intracellular glutathione in human peritoneal mesothelial cells exposedin vitro to dialysis fluid.(submitted)
22. De Fijter CWH, Verbrugh HA, Peters EDJ,et al. In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD. Clin Nephrol 1993; 39:75-80.
23. Jörres A, Topley N, Steenweg L, et al. Inhibition of cytokine synthesis by peritoneal dialysate persists throughout the CAPD cycle. Am J Nephrol 1992; 12:80-5.
24. Haag-Weber M, Horl WH. Impact of continuous ambulatory peritoneal dialysis solutions and clearance of macromolecules on polymorphonuclear neutrophils. Perit Dial Int 1994; 14 (Suppl 3):S33-S38.
25. Steinhauer HB, Brugger U, Atmanspacher R, et al. Effect of CAPD dialysate on the release of eicosanoids and cytokines from human peritoneal macrophages. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin Inc., 1992:47-52.
26. Daniels I, Lindsay M, Porter C,et al. Effect of peritoneal dialysis effluent on Superoxide anion production by polymorphonuclear neutrophils. Nephron 1993; 64:382-7.
27. Selgas R, Lopez-Rias A, Alvaro F, et al. Insulin influence (used as additive to dialysate) on the mitogenic-induced effect of the peritoneal effluent in CAPD patients. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin Inc., 1989:161-4.
28. Breborowicz A, Oreopoulos DG. Physiological approaches to increase biocompatibility of peritoneal dialysis. Perit Dial Int 1995; 15 (Suppl 7):S76-86.